<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04829526</url>
  </required_header>
  <id_info>
    <org_study_id>2021-00402; ko21Sutter</org_study_id>
    <nct_id>NCT04829526</nct_id>
  </id_info>
  <brief_title>Firm Observational Clinical Unicenter Study on Guillain Barré Syndrome</brief_title>
  <acronym>FOCUS on GBS</acronym>
  <official_title>Firm Observational Clinical Unicenter Study on Guillain Barré Syndrome (FOCUS on GBS)</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University Hospital, Basel, Switzerland</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University Hospital, Basel, Switzerland</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The aim of this retrospective observational single-center cohort study is to gain a deeper&#xD;
      understanding regarding the frequency, the clinical and electrophysiologic characteristics&#xD;
      (e.g., the diagnostic work up), complications, treatment regimes, and their associations with&#xD;
      specific courses of disease and outcomes in adult patients with the suspected or proven&#xD;
      diagnosis of GBS.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Guillain Barré Syndrome (GBS) is a rare and life-threatening neurological emergency. The aim&#xD;
      of this retrospective study including adult GBS patients from the last 15 years treated at&#xD;
      the University Hospital of Basel is to assess data regarding diagnostic workup, treatment,&#xD;
      clinical course including complications and outcomes.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">March 1, 2021</start_date>
  <completion_date type="Anticipated">December 2022</completion_date>
  <primary_completion_date type="Anticipated">December 2022</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Retrospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>frequency of GBS</measure>
    <time_frame>one time retrospective assessment at baseline</time_frame>
    <description>frequency of GBS of all consecutive adult patients with the suspected initial diagnosis of GBS (admitted to the University Hospital Basel)</description>
  </primary_outcome>
  <primary_outcome>
    <measure>clinical characteristics of GBS</measure>
    <time_frame>one time retrospective assessment at baseline</time_frame>
    <description>clinical characteristics of GBS of all consecutive adult patients with the suspected initial diagnosis of GBS (admitted to the University Hospital Basel)</description>
  </primary_outcome>
  <primary_outcome>
    <measure>electrophysiologic characteristics of GBS</measure>
    <time_frame>one time retrospective assessment at baseline</time_frame>
    <description>electrophysiologic characteristics of GBS of all consecutive adult patients with the suspected initial diagnosis of GBS (admitted to the University Hospital Basel)</description>
  </primary_outcome>
  <primary_outcome>
    <measure>complications of GBS</measure>
    <time_frame>one time retrospective assessment at baseline</time_frame>
    <description>complications of GBS of all consecutive adult patients with the suspected initial diagnosis of GBS (admitted to the University Hospital Basel)</description>
  </primary_outcome>
  <primary_outcome>
    <measure>treatment regimes of GBS</measure>
    <time_frame>one time retrospective assessment at baseline</time_frame>
    <description>treatment regimes of GBS of all consecutive adult patients with the suspected initial diagnosis of GBS (admitted to the University Hospital Basel)</description>
  </primary_outcome>
  <primary_outcome>
    <measure>outcomes of GBS</measure>
    <time_frame>one time retrospective assessment at baseline</time_frame>
    <description>treatment regimes of GBS of all consecutive adult patients with the suspected initial diagnosis of GBS (admitted to the University Hospital Basel)</description>
  </primary_outcome>
  <enrollment type="Anticipated">100</enrollment>
  <condition>Guillain-Barre Syndrome (GBS)</condition>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>data collection</intervention_name>
    <description>Retrospective extraction of demographic, clinical, laboratory, and electrophysiological data from the digital medical records</description>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        patients with the suspected and with the final proven diagnosis of GBS in the years&#xD;
        2005-2021&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  suspected diagnosis of GBS, who have been treated at the University Hospital of Basel&#xD;
             from 01.01.2005-28.02.2021&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Patients with documented refusal of the general consent.&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Raoul Sutter, Prof. Dr. med.</last_name>
    <role>Principal Investigator</role>
    <affiliation>Clinic for Intensive Care Medicine, University Hospital Basel</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Raoul Sutter, Prof. Dr. med.</last_name>
    <phone>+41 61 32 87 928</phone>
    <email>raoul.sutter@usb.ch</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Lisa Hert, Dr. med.</last_name>
    <email>lisa.hert@usb.ch</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Clinic for Intensive Care Medicine; University Hospital Basel</name>
      <address>
        <city>Basel</city>
        <zip>4031</zip>
        <country>Switzerland</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Raoul Sutter, Prof. Dr. med.</last_name>
      <email>raoul.sutter@usb.ch</email>
    </contact>
    <contact_backup>
      <last_name>Lisa Hert, Dr. med.</last_name>
      <email>lisa.hert@usb.ch</email>
    </contact_backup>
    <investigator>
      <last_name>Raoul Sutter, Prof. Dr. med.</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Lisa Hert, Dr. med.</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Switzerland</country>
  </location_countries>
  <verification_date>April 2021</verification_date>
  <study_first_submitted>March 29, 2021</study_first_submitted>
  <study_first_submitted_qc>April 1, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">April 2, 2021</study_first_posted>
  <last_update_submitted>April 1, 2021</last_update_submitted>
  <last_update_submitted_qc>April 1, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">April 2, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Guillain-Barre Syndrome</mesh_term>
    <mesh_term>Syndrome</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

